Kristen Fortney, BioAge Labs CEO
Novartis turns to BioAge for new targets based on longevity and exercise
BioAge Labs, which began nearly a decade ago as an anti-aging biotech and then turned to obesity this year, is going back to its roots …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
